|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||85.81 - 88.68|
|52 Week Range||71.35 - 99.26|
|PE Ratio (TTM)||21.08|
|Earnings Date||Apr 25, 2018|
|Forward Dividend & Yield||1.00 (1.17%)|
|1y Target Est||109.00|
His pay is larger than the CEOs at Raymond James, Bloomin' Brands and a half-dozen other bigger companies.
Reversal in trading activities, stable underwriting fees and higher interest rates are expected to support Raymond James' (RJF) Q2 earnings.
Charles Schwab (SCHW) has a price-to-earnings ratio of 20.80x on an NTM (next-12-month) basis, which implies a premium valuation, as the average for competitors is 11.30x. Morgan Stanley (MS), Wells Fargo (WFC), and Raymond James Financial (RJF) have price-to-earnings ratios of 11.26x, 10.55x, and 12.10x, respectively, on an NTM basis.
Charles Schwab’s (SCHW) total expenses excluding interest amounted to $1.4 billion in 1Q18, which implies a rise sequentially and YoY (year-over-year). Charles Schwab’s compensation and benefits expenses amounted to $770 million in 1Q18 compared to $711 million in 4Q17, which implies an 8% increase. Charles Schwab incurred professional services expenses amounting to $156 million in 1Q18, while in 1Q17, it incurred $133 million, a rise of 17%.
Charles Schwab (SCHW) ended 1Q18 with total client assets amounting to $3.3 trillion, a fall compared to 4Q17 but a rise on a year-over-year basis. In 1Q18, the company posted total proprietary mutual funds amounting to $228.4 billion, while in 4Q17, the figure stood at $246.1 billion. This decline was mainly because of a fall in money market funds from $163.6 billion in 4Q17 to $145 billion in 1Q18.
Charles Schwab (SCHW) posted earnings per share (or EPS) of $0.55 in 1Q18, which exceeded expectations by $0.02. Brokerages (XLF) have benefitted from market volatility, as it prompts customers to increase trading activity.
NEW YORK, April 19, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Alexion Pharmaceuticals (ALXN) is one of the leading biotechnology firms. Soliris is approved to treat aHUS (atypical hemolytic uremic syndrome) and PHN (paroxysmal nocturnal hemoglobinuria). Alexion’s latest acquisition of Wilson Therapeutics is a turnaround strategy that’s being implemented to restructure Alexion’s performance and investors’ sentiments in the market.
The lawsuit could have major implications for Downtown Memphis, as more than 600 Raymond James employees work at the 50 North Front St. building.
DEAN HOOVER JOINS STEWARD PARTNERS' CLEARWATER OFFICE WASHINGTON , April 9, 2018 /PRNewswire/ -- Steward Partners Global Advisory, LLC, an employee-owned, full-service independent partnership associated ...
Alex. Brown — the first investment bank in the U.S. — was formerly one of Baltimore's biggest names. But the company has been coming back strong since Raymond James Financial Inc. acquired it from Deutsche Bank in 2016.
The museum, located at 150 Central Ave., was built with the idea of transforming a downtown St. Petersburg city block with more than just artwork.
Lisa Detanna, AIF® Senior Vice President, Investments, Managing Director with Raymond James & Associates, Inc., member New York Stock Exchange/SIPC, was among the Raymond James-affiliated advisors named to the Forbes list of Best-In-State Wealth Advisors.
Charles Schwab (SCHW) incurred total expenses excluding interest of $5.0 billion in 2017, representing an 11% rise on a year-over-year basis mainly due to professional services as well as compensation and benefits. This rise was witnessed mainly because of a rise in its number of employees and higher annual salaries. Charles Schwab incurred incentive compensation expenses of $797 million in 2017 compared to $689 million in 2016.
WITH $600 MILLION IN ASSETS, THE PRICE GROUP OPENS STEWARD PARTNERS' 14TH OFFICE AND FIRST LOCATION IN TEXAS WASHINGTON , March 28, 2018 /PRNewswire/ -- Steward Partners Global Advisory, LLC, an employee-owned, ...
Charles Schwab (SCHW) is of the view that though the Trump administration has levied tariffs on steel and aluminum, investors shouldn’t stop thinking about global exposure. The company also believes that in order to maintain global exposure, of its total stock investments, 25%–50% should be deployed beyond US borders. After the Trump administration made the tariff announcement, a major concern among investors was what other countries would do in response to the move.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting RJF. Over the last one-month, outflows of investor capital in ETFs holding RJF totaled $2.10 billion.
Assessing Raymond James Financial Inc’s (NYSE:RJF) past track record of performance is a useful exercise for investors. It allows us to understand whether the company has met or exceed expectations,Read More...